AI-powered search
AI-powered search

Live Evaluations

Therapeutic Options in Vitiligo Treatment: An Evolving Landscape


Therapeutic Options in Vitiligo Treatment: An Evolving Landscape

This activity is supported by an educational grant from Incyte.

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Describe the role of emerging therapies for the treatment and management of vitiligo.

  • Describe strategies to individualize care when using emerging therapies for vitiligo.

  • Identify techniques for incorporating emerging vitiligo therapies into everyday practice.

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Andrew Alexis, MD, MPH

Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology 
Weill Cornell Medicine
New York, NY

Seemal Desai, MD

Clinical Assistant Professor 
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Andrew F. Alexis, MD, MPH

Grant/Research Support: BMS, LEO, Novartis, Almirall

Consultant: Leo, Galderma, Pfizer, Sanofi- Regeneron

Speakers’ Bureau or Honoraria: Regeneron, SANOFI-Genzyme, Pfizer, BMS

Seemal R. Desai, MD

Grant/Research Support: AbbVie, Incyte, Dermavant, AOBiome,

Consultant: Galderma, Almirall, Ferndale, BMS, AbbVie, Verrica, UCB, Ortho, Scientis, EPI, Avita, Eli Lilly, Leo, Pfizer, Incyte, L’Oreal, Beiersdorf, J&J

Speakers’ Bureau or Honoraria: Dermavant, Galderma, Pfizer

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved